RSS Feed - Life Sciences - Antitrust - Kaye Scholer LLP
Current Feed: http://www.kayescholer.com/practice/rss.xml?p=life_sciences_antitrust
Mark Godler (03/28/14)
Mark Godler has over thirty years of legal experience encompassing a broad range of litigation work and counseling services, with special focus on intellectual property, commercial disputes and antitrust issues. He has worked closely with clients in the pharmaceutical, entertainment, publishing, fashion, textile and cosmetic industries, providing practical advice designed to balance strategic legal considerations with financial realities.
Karin E. Garvey (03/28/14)
Karin Garvey practices complex commercial litigation and has considerable experience in antitrust disputes. She has practiced before both state and federal courts and has also participated in alternative dispute resolution such as arbitration and mediation.
Aton Arbisser (03/26/14)
Aton Arbisser is the Chair of the Litigation Department of Kaye Scholer’s Los Angeles office and part of the firm’s Antitrust and Product Liability groups.
Diana Sterk (03/26/14)
Diana Sterk is an Associate in Kaye Scholer’s Complex Commercial Litigation Department. Her recent experience includes representing pharmaceutical manufacturers in government actions concerning drug pricing and Medicaid reimbursement, representing major financial institutions in SEC and FINRA investigations and inquiries and defending corporations in complex state and federal investigations involving healthcare fraud, including allegations of off-label promotion, anti-kickback statute violations, False Claims Act violations and other issues related to sales, marketing and pricing practices. Diana is also a contributor to the antitrust chapter of Kaye Scholer’s Deskbook on Pharmaceutical and Biotech Patent Law.
Randolph S. Sherman (03/26/14)
In his 43 years of practice, Randolph S. Sherman, Former Chair of Kaye Scholer’s Litigation Department, has handled a wide variety of complex litigation, including products liability, antitrust, false advertising, trademarks, trade dress, derivatives, insurance, employment discrimination and contract disputes, for clients such as Novartis, CIBA Vision, R.J. Reynolds Tobacco Company, Texaco Inc., W.R. Grace and The Walt Disney Company.
Saul P. Morgenstern (03/24/14)
Saul Morgenstern, Co-Chair of the firm’s Antitrust practice, litigates complex disputes, class actions and multi-jurisdictional cases before US federal and state courts, international arbitral tribunals, the Federal Trade Commission and the US International Trade Commission, and represents clients in US Government, State and foreign investigations. He also advises companies with respect to the antitrust implications of mergers, acquisitions, joint ventures, trade association activities, distribution and pricing programs and other aspects of competitor and customer relations. Saul has represented clients across a broad spectrum of industries, including the chemical, computer hardware and software, energy, entertainment, insurance, financial, leisure, luxury consumer goods, pharmaceutical, publishing, real estate, telecommunications and toy industries.
Robert Grass (03/24/14)
Robert Grass practices in the Complex Commercial Litigation and Product Liability groups of the firm’s Litigation Department. Robert’s practice includes representation of pharmaceutical manufacturers and construction firms in product liability actions in both state and federal courts. He has represented clients in the defense of consumer fraud actions, including by consumers and third-party payors seeking to recover amounts paid for prescription medicines, as well. He has vast experience in multidistrict litigations and in defending class actions.
Claudia R. Higgins (03/12/14)
Claudia Higgins joined Kaye Scholer following over two decades of distinguished service as an antitrust litigator with the Federal Trade Commission (FTC). An antitrust partner in the firm’s Complex Commercial Litigation department, Claudia represents Fortune 500 companies in significant antitrust matters, particularly high-profile mergers, acquisitions and joint ventures, as well as in private antitrust litigation and civil investigations by the FTC, the US Department of Justice (DOJ), and numerous international regulatory agencies. Her experience in antitrust matters spans a widely diverse set of industries, including consumer goods, defense and aerospace, natural resources, technology and health care.